Medicare's Weight-Loss Drug Coverage Proposal Sparks Debate

The Biden administration has proposed expanding Medicare and Medicaid coverage to include weight-loss drugs, potentially benefiting 7.5 million people and adding significant costs to federal programs. This move, aimed at addressing obesity as a chronic disease, faces opposition from Robert F. Kennedy Jr., the incoming HHS secretary under the Trump administration, who criticizes reliance on such medications. The proposal has sparked debate over the financial implications and the need for a comprehensive approach to obesity, including lifestyle changes and behavioral therapy.